Overall rank by patents
#32,769
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C02F (TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE).
The verdict
Ostara holds 8 US patents across 8 technology areas, rank #32,769 of 50,000 tracked assignees.
Ostara Nutrient Recovery Technologies Inc. has been granted 8 US utility patents between 2015 and 2024, placing Ostara Nutrient Recovery Technologies Inc. at rank #32,769 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 27.9 claims per patent with primary concentration in C02F (TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE). As a Foreign Corporation, Ostara Nutrient Recovery Technologies Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Ostara sits between Orthodyne Electronics Corporation (8 patents, rank #32,765) and Otto Aero Company (8 patents, rank #32,773) - the closest US assignees by grant volume. The composite Innovation Score of 33.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 6 in the 2015–2019 window, a -67% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ostara Nutrient Recovery Technologies Inc.'s 27.9 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ostara Nutrient Recovery Technologies Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Orthodyne Electronics Corporation
8 patents
Ortiz and Associates Consulting, LLC
8 patents
Osborne Industries Inc.
8 patents
Oso Perforating, LLC
8 patents
Osteoplastics, LLC
8 patents
Othair Prothena Limited
8 patents
Ott-Jakob Spanntechnik GmbH
8 patents
Otto Aero Company
8 patents
Ostara Nutrient Recovery Technologies Inc.
8 patents
What this shows Ostara holds 8 patents at rank #32,769, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,769 in granted patent volume.
Other assignees with the most granted patents in Ostara's primary technology class.
Ostara's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 54% higher than 46% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2019 | 4 | 50.0% |
| 2021 | 1 | 12.5% |
| 2024 | 1 | 12.5% |
Top 8 of 8 technology areas
Overall rank by patents
#32,769
Across all tracked assignees
33.9 out of 100
How to use this portfolio
Ostara's 8 grants land it in the top 54% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.